Unimicron Technology (3037) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Apr, 2026Executive summary
Net sales for Q4 2025 reached NT$34,691M, up 2% sequentially and 14% year-over-year to NT$131,241M for the full year.
Consolidated financial statements for 2025 and 2024 were audited and present fairly the financial position and performance in accordance with IFRS as endorsed by the FSC.
The Group is primarily engaged in manufacturing and sales of electronic components, with 31,448 employees as of December 31, 2025.
Net income for Q4 2025 was NT$3,916M, a 60% increase sequentially; full-year net income rose 36% year-over-year to NT$7,550M.
Financial highlights
Sales revenue increased to NT$131,240,882 thousand in 2025, up 14% year-over-year from NT$115,373,282 thousand.
Operating income in Q4 2025 was NT$2,366M, up 54% from Q3 2025; full-year operating income increased 30% year-over-year.
EBITDA for Q4 2025 was NT$9,297M (27% of sales); full-year EBITDA reached NT$28,555M (22% of sales).
Basic EPS for 2025 was NT$4.38, up from NT$3.34 in 2024.
Total assets grew to NT$255,791,612 thousand at year-end 2025, up from NT$230,846,946 thousand.
Outlook and guidance
Forward-looking statements highlight risks and uncertainties that may impact future performance.
The Board of Directors proposed a cash dividend of NT$2.00 per share for 2025, pending shareholder approval.
The Group continues to monitor the impact of new IFRS standards and Pillar Two tax legislation, with no material exposure to top-up tax as of year-end.
Latest events from Unimicron Technology
- Net sales up 12% to NT$96.55B, net income down 38%, with new bonds and HK listing planned.3037
Q3 202512 Dec 2025 - Revenue up 15% but profit and margins fell sharply amid major merger and FX risks.3037
Q2 20258 Sep 2025 - Q1 2025 revenue rose 14% year-over-year, but net income and margins declined.3037
Q1 202519 Jun 2025 - Sales up 13.8% in Q3 2024, but net income and margins declined amid expansion efforts.3037
Q3 202413 Jun 2025 - Revenue rose but profit and margins fell due to higher costs and margin pressure.3037
Q2 202413 Jun 2025 - Sales up 11%, net income down 55–58%, dividend proposed, inventory risk persists.3037
Q4 20245 Jun 2025